Shamrock - Ultrasound/MR Image Fusion Guided Lumbar Plexus Block

NCT ID: NCT02718976

Last Updated: 2016-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to complete a double-blinded randomized controlled crossover trial of lumbar plexus block with the Shamrock technique guided by ultrasound (US)/magnetic resonance imaging (MRI) image fusion vs. the Shamrock technique guided by ultrasound in healthy volunteers.

The investigators will assess block procedure-related parameters, anatomical spread of local anesthetic, and motor and sensory effects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures Anesthesia, Local Pain, Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Shamrock guided by US/MR image fusion

Use of US/MR image fusion guided Shamrock technique to place lumbar plexus block (20 ml 2% lidocaine with epinephrine added gadoterate meglumine).

Group Type EXPERIMENTAL

Ultrasound/MR image fusion guided lumbar plexus block (Shamrock)

Intervention Type PROCEDURE

Lidocaine-epinephrine added gadoterate meglumine

Intervention Type DRUG

Perineural injection of 20 ml 2% lidocaine with 0.0005% epinephrine added 1 ml of gadoterate meglumine (0.13 ml) and sodium chloride (NaCl, 0.87 ml). The 1 ml of gadoterate meglumine-NaCl is added to the local anesthetic prior to the perineural injection in order to enhance visualization of the local anesthetic on MRI scanning after the intervention.

Shamrock guided by US

Use of US guided Shamrock technique to place lumbar plexus block (20 ml 2% lidocaine with epinephrine added gadoterate meglumine).

Group Type OTHER

Ultrasound guided lumbar plexus block (Shamrock)

Intervention Type PROCEDURE

Lidocaine-epinephrine added gadoterate meglumine

Intervention Type DRUG

Perineural injection of 20 ml 2% lidocaine with 0.0005% epinephrine added 1 ml of gadoterate meglumine (0.13 ml) and sodium chloride (NaCl, 0.87 ml). The 1 ml of gadoterate meglumine-NaCl is added to the local anesthetic prior to the perineural injection in order to enhance visualization of the local anesthetic on MRI scanning after the intervention.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound/MR image fusion guided lumbar plexus block (Shamrock)

Intervention Type PROCEDURE

Ultrasound guided lumbar plexus block (Shamrock)

Intervention Type PROCEDURE

Lidocaine-epinephrine added gadoterate meglumine

Perineural injection of 20 ml 2% lidocaine with 0.0005% epinephrine added 1 ml of gadoterate meglumine (0.13 ml) and sodium chloride (NaCl, 0.87 ml). The 1 ml of gadoterate meglumine-NaCl is added to the local anesthetic prior to the perineural injection in order to enhance visualization of the local anesthetic on MRI scanning after the intervention.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Body mass index (BMI): 18.5 ≤ BMI ≤30
* Written and oral consent to participate
* Normal healthy person (American Society of Anesthesiology Classification I)

Exclusion Criteria

* Volunteers not abel to speak or understand Danish
* Volunteers not able to cooperate
* Allergy against the medicines used in the study
* Daily use of analgesics
* Drug abuse - according to the investigator's judgment
* Alcohol consumption greater than the recommendations of the Danish National Board of Health
* Contraindication for MRI scan (including pregnancy)
* Volunteers in whom nerve blocks are impossible due to technical reasons or infection
* Volunteers who are incompetent, eg. surrogate consent is unaccepted
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bendtsen, Thomas Fichtner, M.D, Ph.D.

UNKNOWN

Sponsor Role collaborator

AP Moeller Foundation

OTHER

Sponsor Role collaborator

Aarhus University Hospital

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennie MC Strid, M.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Anesthesiology and Intensive Care, Aarhus University Offical

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AUH-TFB-SR-ULMR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.